Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.23
(-4.17%)
CAD 0.23
(-4.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.02 Million CAD | 142.82% |
| 2022 | 423.78 Thousand CAD | 206.03% |
| 2021 | 138.47 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 878 Thousand CAD | -14.68% |
| 2024 Q3 | 883.6 Thousand CAD | -22.37% |
| 2024 Q2 | 1.13 Million CAD | 29.63% |
| 2023 Q4 | 1.02 Million CAD | 26.67% |
| 2023 FY | 1.02 Million CAD | 142.82% |
| 2023 Q2 | 753.88 Thousand CAD | 8.74% |
| 2023 Q3 | 812.34 Thousand CAD | 7.75% |
| 2023 Q1 | 693.29 Thousand CAD | 63.6% |
| 2022 Q4 | 423.78 Thousand CAD | 41.64% |
| 2022 Q3 | 299.19 Thousand CAD | -37.89% |
| 2022 Q2 | 481.74 Thousand CAD | 259.8% |
| 2022 Q1 | 133.89 Thousand CAD | 0.0% |
| 2022 FY | 423.78 Thousand CAD | 206.03% |
| 2021 FY | 138.47 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 2.71 Million CAD | 62.165% |
| Asep Medical Holdings Inc | 3.05 Million CAD | 66.282% |
| BetterLife Pharma Inc. | 8.02 Million CAD | 87.17% |
| BioVaxys Technology Corp. | 3.48 Million CAD | 70.477% |
| ChitogenX Inc. | 6.71 Million CAD | 84.669% |
| Rapid Dose Therapeutics Corp. | 5.04 Million CAD | 79.596% |
| Defence Therapeutics Inc. | 4.06 Million CAD | 74.667% |
| Entheon Biomedical Corp. | 85.32 Thousand CAD | -1105.989% |
| Gemina Laboratories Ltd. | 3.04 Million CAD | 66.167% |
| Glow Lifetech Corp. | 2.34 Million CAD | 56.14% |
| Lexston Life Sciences Corp. | 39.86 Thousand CAD | -2481.008% |
| Doseology Sciences Inc. | 82.49 Thousand CAD | -1147.42% |
| MYND Life Sciences Inc. | 5.77 Million CAD | 82.181% |
| Nova Mentis Life Science Corp. | 841.66 Thousand CAD | -22.261% |
| PharmaTher Holdings Ltd. | 252.9 Thousand CAD | -306.887% |
| PreveCeutical Medical Inc. | 5.95 Million CAD | 82.734% |
| Telescope Innovations Corp. | 1.35 Million CAD | 23.834% |